文献
J-GLOBAL ID:202202222782108461
整理番号:22A0858658
抗癌剤の価値-規制的観点【JST・京大機械翻訳】
The value of anticancer drugs - a regulatory view
著者 (9件):
Pignatti Francesco
(Oncology & Haematology Office, European Medicines Agency, Amsterdam, Netherlands)
,
Wilking Ulla
(Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden)
,
Postmus Douwe
(Oncology & Haematology Office, European Medicines Agency, Amsterdam, Netherlands)
,
Postmus Douwe
(Department of Epidemiology, University of Groningen, University Medical Centre, Groningen, Netherlands)
,
Wilking Nils
(Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden)
,
Delgado Julio
(Oncology & Haematology Office, European Medicines Agency, Amsterdam, Netherlands)
,
Delgado Julio
(Department of Haematology, Hospital Clinic, Barcelona, Spain)
,
Bergh Jonas
(Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden)
,
Bergh Jonas
(Breast Cancer Centre, Theme Cancer, Karolinska University Hospital, Karolinska Comprehensive Cancer Centre, Solna, Sweden)
資料名:
Nature Reviews Clinical Oncology
(Nature Reviews Clinical Oncology)
巻:
19
号:
3
ページ:
207-215
発行年:
2022年
JST資料番号:
W4784A
ISSN:
1759-4774
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
ドイツ (DEU)
言語:
英語 (EN)